408 related articles for article (PubMed ID: 26969471)
1. Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.
Zhou J; Huang A; Yang XR
J Gastrointest Cancer; 2016 Jun; 47(2):157-67. PubMed ID: 26969471
[TBL] [Abstract][Full Text] [Related]
2. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.
Yin CQ; Yuan CH; Qu Z; Guan Q; Chen H; Wang FB
Dis Markers; 2016; 2016():1427849. PubMed ID: 27403030
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Ye Q; Ling S; Zheng S; Xu X
Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
[TBL] [Abstract][Full Text] [Related]
5. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
Zhang X; Ju S; Wang X; Cong H
Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
Shaik MR; Sagar PR; Shaik NA; Randhawa N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsies in Oncology and the Current Regulatory Landscape.
Strotman LN; Millner LM; Valdes R; Linder MW
Mol Diagn Ther; 2016 Oct; 20(5):429-36. PubMed ID: 27324559
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy: ready to guide therapy in advanced prostate cancer?
Hegemann M; Stenzl A; Bedke J; Chi KN; Black PC; Todenhöfer T
BJU Int; 2016 Dec; 118(6):855-863. PubMed ID: 27430478
[TBL] [Abstract][Full Text] [Related]
9. Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Ogle LF; Orr JG; Willoughby CE; Hutton C; McPherson S; Plummer R; Boddy AV; Curtin NJ; Jamieson D; Reeves HL
J Hepatol; 2016 Aug; 65(2):305-13. PubMed ID: 27132171
[TBL] [Abstract][Full Text] [Related]
10. A headlight on liquid biopsies: a challenging tool for breast cancer management.
Massihnia D; Perez A; Bazan V; Bronte G; Castiglia M; Fanale D; Barraco N; Cangemi A; Di Piazza F; Calò V; Rizzo S; Cicero G; Pantuso G; Russo A
Tumour Biol; 2016 Apr; 37(4):4263-73. PubMed ID: 26790442
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
12. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
Alix-Panabières C; Pantel K
Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
[TBL] [Abstract][Full Text] [Related]
13. Developments and current status of cell-free DNA in the early detection and management of hepatocellular carcinoma.
Du S; Cao K; Yan Y; Wang Y; Wang Z; Lin D
J Gastroenterol Hepatol; 2024 Feb; 39(2):231-244. PubMed ID: 37990622
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
[TBL] [Abstract][Full Text] [Related]
15. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
Jiang P; Chan KCA; Lo YMD
J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.
Venesio T; Siravegna G; Bardelli A; Sapino A
Pathobiology; 2018; 85(1-2):146-154. PubMed ID: 28614831
[TBL] [Abstract][Full Text] [Related]
17. Future perspectives of circulating tumor DNA in colorectal cancer.
Nadal C; Winder T; Gerger A; Tougeron D
Tumour Biol; 2017 May; 39(5):1010428317705749. PubMed ID: 28488528
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives.
Zhang Y; Li J; Cao L; Xu W; Yin Z
Semin Oncol; 2012 Aug; 39(4):449-60. PubMed ID: 22846862
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsies for Assessing Metastatic Melanoma Progression.
Huynh K; Hoon DS
Crit Rev Oncog; 2016; 21(1-2):141-54. PubMed ID: 27481010
[TBL] [Abstract][Full Text] [Related]
20. Capturing circulating tumor cells of hepatocellular carcinoma.
Wu LJ; Pan YD; Pei XY; Chen H; Nguyen S; Kashyap A; Liu J; Wu J
Cancer Lett; 2012 Dec; 326(1):17-22. PubMed ID: 22842097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
